Communicating personalized genomic risk results for common diseases to the general population as a form of tailored prevention is novel and may require alternative genetic counseling service delivery models. We describe the development and evaluation of a communication protocol for disclosing melanoma genomic risk information to the asymptomatic general population and assess participants' satisfaction and acceptability. Participants (n = 117) were aged 22-69 years, living in New South Wales, Australia and unselected for family history. They provided a saliva sample and had genomic testing for melanoma for low to moderate penetrant melanoma susceptibility variants in 21 genes. Participants could choose to receive their results from a genetic counselor via telephone, followed by a mailed booklet or to receive their risk result via mailed booklet only with a follow-up call for those at high risk. A followup questionnaire was completed by 85% of participants 3-months later. Most participants (80%) elected to receive their result via telephone. Participants were highly satisfied with the delivery of results (mean 3.4 out of 4, standard deviation 0.5), and this did not differ by delivery mode, risk category, age or sex. On follow-up, 75% accurately recalled their risk category, 6% indicated a preference for a different delivery mode, either electronic or face-to-face. The process of disclosing genomic risk results to the general population over the telephone with accompanying written material was feasible and acceptable, and may be useful for communicating polygenic risk for common diseases in the context of increasing demands for genomic testing.
Introduction
Personalized genomic testing for asymptomatic individuals could be used to tailor disease prevention and screening of individuals based on their genotype (Burton et al. 2013; McBride et al. 2012) , and may be used to motivate risk appropriate preventative and early detection behaviors (Smit et al. 2017; Smit et al. 2015) . The genetic counseling model of providing pre and post-test counseling via face-to-face sessions to individuals undergoing genetic testing for rare high-penetrance diseases is the most common service delivery model used in Australia and internationally (Cohen et al. 2013; Godard et al. 2003 ; Human Genetics Society of Australasia 2012). However, it may not be appropriate nor feasible for delivering genomic test results on a wider general population scale to reveal low to moderate risk estimates for common, polygenic diseases.
Genomic testing is anticipated to have different psychological and behavioral impacts on individuals and their family compared to high-penetrance genetic testing (Graves et al. 2013; McBride et al. 2015) . Thus, the development of alternative genetic counseling delivery models may be required.
In recent years, there has been an increased use of non-traditional genetic counseling service delivery to meet the growing demand for cancer genetic testing (Buchanan et al. 2016) and in response to rapid technological advances in genetic and genomic testing (Shelton and Whitcomb 2015) , yet limited research data has been published. There is a need for a greater understanding of needs, preferences and expectations of genomic testing within the asymptomatic general population and the provision of genetic counseling in this context (Schmidlen et al. 2014 ). In particular, there is increasing interest in the potential use of genomics risk information for population-based risk stratification and to inform personalized prevention and early detection recommendations (Burton et al. 2013; Foulkes et al. 2016; Modell et al. 2014) .
This paper describes the development, implementation and evaluation of a telephone communication protocol for disclosing personal genomic risk of melanoma information to people without a personal history of melanoma and unselected for family history. It is estimated that the majority of melanomas in high-incidence countries are caused by sun exposure and could be prevented through personal behaviors including reduced sun exposure (Armstrong and Kricker 1993) and sunscreen use (Green et al. 2011) . Additionally self-conducted and clinical skin examinations are associated with early detection and probably reduce melanoma mortality (Weinstock 2012) . Providing genomic risk information to the general population is a potential strategy to improve these melanoma prevention and screening behaviors. Traditionally, genetic testing for melanoma has been limited to germline mutation testing of the high-penetrant CDKN2A gene in individuals with a personal and family history of invasive melanoma (Leachman et al. 2017) . The offer of genomic testing for low to moderate penetrant melanoma susceptibility variants to the general population is novel, and this is the first evaluation of genetic counseling in this setting. The results from this study will be relevant to the delivery of personalized genomic testing for other common, complex diseases. This paper aims to: 1) describe the development and evaluation of a communication protocol for disclosing melanoma risk information and delivering education to the asymptomatic general population within a research context; and 2) assess satisfaction and acceptability with genetic counseling using this communication protocol.
Methods

Study Design and Participants
The communication protocol was developed as part of a pilot randomized controlled trial that examined the feasibility, acceptability and impact of delivering personalized genomic risk of melanoma information to the public (Smit et al. 2017) . Participants in the pilot trial were recruited from the Cancer Council NSW BJoin a Research Study^database, which comprises individuals with cancer, relatives, friends as well as the general public, who have agreed to be contacted for ethicallyapproved cancer research studies. Individuals eligible for recruitment into the current study were aged 18-69 years, had no personal history of melanoma, were residing in the state of New South Wales (NSW) Australia and had sufficient English language abilities to complete questionnaires. Ethics approval was obtained from The University of Sydney. All participants provided written consent to participate and telephone access to a study-dedicated genetic counselor was available at the time of consent. We report our study according to the Standards for the Reporting of Genetic Counseling Interventions in Research and Other Studies (Hooker et al. 2017) .
In the pilot trial, all participants provided a DNA sample for genotyping and completed a baseline questionnaire, which included questions about personal and family history of all cancers. Participants were randomly allocated to either the intervention or waitlist control arm and all participants were offered information about their personal genomic risk of melanoma. The participants in the intervention arm received their genomic risk results during the main study before the initial follow-up outcomes were assessed. After data collection was completed for the main study, participants in the waitlist control arm were offered their risk results and were followed up the same way as for the intervention arm. The two-arm approach in the main trial allowed analyses comparing the effects of giving personalized genomic risk information versus not giving this information across numerous outcomes including the impact on sun exposure, sun protection and skin examination behaviors and broader social and psychological outcomes. These behavioral results and the specific details on the genotyping and calculation of the melanoma risk estimates have been reported previously (Smit et al. 2017 ). The only difference between the study-arms was the expected waiting time from providing a saliva sample to receiving results (intervention arm approximately 4 months; control arm approximately 8 months). The delivery of the risk results was consistent between the intervention and waitlist control groups, and therefore the relevant data from both study-arms are combined in this sub-study analysis.
Development of the Telephone-Based Communication Protocol and Risk Disclosure Process
The communication protocol was based on findings from our focus group study that explored communication strategies for genomic risk information (Smit et al. 2016; Smit et al. 2015) , literature on telephone genetic counseling (Baumanis et al. 2009; Christensen et al. 2011; Peshkin et al. 2016 ) and a protocol developed by Patrick-Miller et al. (2014) for disclosing BRCA1/2 test results by telephone. Patrick-Miller et al.'s (2014) protocol was designed to be adaptable to the communication of genetic and genomic test results and associated risk reduction strategies. Our protocol consisted of four sections: (1) the risk disclosure process; (2) the presentation of risk results (in verbal and written formats); (3) the provision of skin cancer education material and (4) discussion themes, which comprised responses to potential participant questions.
A review of the communication protocol prior to its use was carried out by an expert Advisory Group, comprising certified genetic counselors with experience in cancer genetics, an expert in public health genetics and education, and an experienced cancer genetics clinician. The study genetic counselors reviewed the protocol on an ongoing basis; revisions were recorded and discussed with the research team.
Risk disclosure process
The study genetic counselor led the disclosure process ( Fig. 1) , and contacted participants via telephone to offer them their genomic risk result, guided by scripts in the communication protocol. This call was always initiated by the genetic counselor; it was not scheduled in advance for a particular time, but participants were offered the option to schedule a call back appointment. The genetic counselor gave each of the participants the option of receiving their result immediately over the telephone, followed by a hard-copy booklet sent via postal mail; or to receive their risk result in a hard-copy booklet sent via postal mail only with a follow-up call for those at high risk. The hard-copy booklet presented and described the participant's personalized melanoma genomic risk result.
The key components of the telephone session were: introductory topics; disclosure of risk information and education; assessment of family history; and the use of verbal probes. Introductory topics involved confirming participants' identity, assessing suitability of call time and affirming the session purpose. Disclosure of risk information required attaining participants' desire and consent for their risk information. Family history assessment involved the genetic counselor crosschecking questionnaire responses with participants and determining participants' eligibility and interest in attending a Family Cancer Clinic. Verbal probes were used to check participants' understanding and address potentially challenging scenarios. All participants were asked BDoes this information make sense so far?^; BIs this the result you were expecting?â nd BDo you have any further questions for me?^. The genetic counselor encouraged all participants to call back if they had any further questions or concerns. During the telephone call, the genetic counselor completed a 20-point checklist that covered all of the key components.
Participants who received their risk result via the mailed hard-copy booklet only received a follow up telephone call from the genetic counselor if they were in the high genomic risk category or if they had a strong family history of cancer (regardless of their risk category).
Personalized genomic risk of melanoma information
The genomic risk information was based on 42 single variants (SNPs) from 21 genes/regions (Smit et al. 2017 ). Participants were not given their individual genotypes, only the risk estimates derived from them. We based the presentation of risk results on disease-risk communication literature and our focus group study (Fagerlin et al. 2007; Hawley et al. 2008; Lautenbach et al. 2013; Smit et al. 2016) . Each participant received a personalized hardcopy booklet sent via postal mail, which contained their remaining lifetime absolute risk as both a percentage and a frequency, a relative risk comparing participants' risk to others of the same age and sex in the general population, and a risk category, for which participants were classified as low, average or high genomic risk. The risk estimates were accompanied by icon arrays (100 person diagrams) (for their personalized risk and for the average person of their age and sex), which is a preferred graphical format for communicating risk information (Smit et al. 2016) , particularly for people with low literacy levels (Hawley et al. 2008) . When participants chose to receive their result via telephone the genetic counselor explained verbally their remaining lifetime absolute risk, their relative risk and risk category, in addition to sending them their personalized booklet.
Generic (non-personalized) skin cancer education information
In addition to their personalized genomic risk booklet, all participants were given a generic educational booklet about general skin cancer prevention and early detection, developed by the research team to help participants take steps to manage their risk. The booklet described melanoma and its causes, preventative behaviors to reduce melanoma including sun protection and self-and doctor-conducted skin checks, information on Vitamin D and provided a list of resources for further information. The participants who elected to receive their risk information over the telephone were given a brief summary of the melanoma prevention and early detection recommendations.
Discussion themes
The communication protocol addressed nine broad discussion themes that the Advisory Group anticipated may be of significance for participants: general study information, potential benefits/harms to participants, study participation requirements, risk result information, prevention and detection of melanoma/skin cancer, risk for other family members, privacy, insurance and support/resources. Standardized responses were prepared for anticipated questions within each discussion theme, ensuring consistency in the provision of information to participants. The genetic counselor documented all the discussion themes raised by participants during the telephone calls.
The genetic counselor requested verbal consent from a sample of participants to audiotape the telephone calls. Interview fidelity checks were performed by an alternate genetic counselor according to Butterfield et al. (2005) , which involved cross checking the content delivered by the genetic counselor with the protocol scripts, the completion of the 20-point checklist and documentation of discussion themes.
Measures of Participant Satisfaction, Recall and Acceptability of Delivery of Results
Participants completed a questionnaire 3-months after receiving their genomic risk information. We measured participant satisfaction with the telephone genetic counseling session and the information provided by the genetic counselor and in the hard-copy personalized booklet. Participants' satisfaction with the genetic counseling telephone session was measured using a validated survey with 10-items scored on a 4-point Likert scale developed by Baumanis et al. (2009) to measure patient satisfaction comparing genetic result disclosure via telephone versus in person. We omitted one question from the original 11-item survey (Once I knew my results were ready, I was able to get them in a reasonable amount of time) because it was not relevant to our study. Participants were asked to strongly disagree, disagree, agree or strongly agree with each statement and a mean satisfaction score for each participant (ranging from 1 to 4) was calculated.
Satisfaction with each of the information provided during the genetic counselor telephone session and with the hardcopy booklet was measured by a question on a 0-10 scale. To test the accuracy of participants' understanding of the risk information, they were asked to recall their result: 'What is your melanoma genetic risk category that you received as part of the study?' with possible responses: low risk, average risk and high risk. To test acceptability of result delivery mode, participants were asked 'Would you have rather received your risk information differently to the way you received it?', and 'If yes, please specify how you would have preferred to receive your risk information?'.
Data Analysis
We used chi-square tests to calculate P-values for differences in participants' satisfaction, acceptability and recall by different subgroups including: genomic risk category (high, average, low), sex, age , and mode of delivery of risk result (telephone, mailed booklet). Statistical significance was inferred at P < 0.05.
Results
Participants
In total, 117 invitees consented to participate in the study (41% consented of those approached), completed baseline questionnaire and genotyping data and agreed to receive their risk result. Baseline characteristics of the participants are shown in Table 1 . There was a high proportion of participants with a family history of melanoma (27%) or a personal and/or family history of other cancers (88%). Although not selected for during recruitment, these high proportions reflect that participants were recruited from a cancer research database. There were 12 participants in the study who were identified from the baseline questionnaire as having a family history suggestive of a hereditary cancer syndrome (10 for breast and ovarian cancer; 1 for Lynch syndrome; 1 for familial melanoma). These participants underwent genomic testing for melanoma as per the study protocol. However, after the genomic risk results had been disclosed, the genetic counselor spoke with each of these participants via telephone to offer a referral to their nearest Family Cancer Clinic, of which 5 participants accepted; 6 had previously attended and 1 declined.
Result Delivery by Telephone and Hard-Copy Booklet
All participants were contacted by a study genetic counselor and informed their risk results were available following a waiting time of on average 3.5 months for the intervention group and 7 months for the waitlist control group. The genetic counselor required more than one telephone attempt to make contact with 50 of the 117 participants (42%), of which 10 participants required between 3 to 6 phone call attempts over a 1 to 6-week period. When asked on the telephone call how they would like to receive their result, most of the participants (n = 93, 79%) elected to receive their result immediately over the telephone followed by mailed hard-copy booklet within 3 working days. The mean duration of the telephone calls that involved disclosing participants risk results was 7 min (range 3-14, standard deviation (SD) 2.8). During the telephone session participants were provided with the opportunity to ask the genetic counselor any questions and 52 of the 93 (56%) participants asked a question/s that led to further information/education being given.
The genetic counselor documented all participant questions and discussion topics, which were grouped by theme ( Table 2 ). The most commonly asked question by participants (16%) was about how their previous sun exposure affected their risk result. Participants also asked how the genetic variants (that were included in their genomic risk estimate calculation) were related to melanoma development (11%); whether their risk result was related to other personal or family cancer diagnoses (10%) and how their risk result affected other family members (9%).
Thirty-nine telephone calls (33%) were audiotaped and fidelity checks revealed that the protocol was consistently followed by the genetic counselor; the checklists correctly corresponded to each participant's telephone session and each discussion theme was documented appropriately.
Result Delivery by Mailed Hard-Copy Booklet
Of the participants that elected to receive their result via mailed booklet only (n = 24, 21%), the genetic counselor provided a mandatory follow up call (according to study protocol) to 11 of these participants because they either received a high-risk result (9 of 11) or they reported a strong family history of cancer that warranted referral to a Family Cancer Clinic (2 of 11). These follow up calls were all initiated by the genetic counselor, who was able to make contact with each of the participants within 1 or 2 phone call attempts over a 2-week period. The mean duration of the follow up calls was 5 min (range 3-11, SD 5.6). Similar discussion topics to those presented in Table 2 were observed during these follow up calls, with no new themes raised by participants. Some participant's reported reasons for choosing to receive their risk results via the mailed booklet were distractions (e.g. children in the home or driving) or lack of privacy (e.g. in a workplace environment) during the initial phone call.
Uptake of Genetic Counseling Access outside of Scheduled Calls
No individuals contacted the genetic counselor at the time of consent when considering enrollment. Once participants were informed of their results, either by telephone or by mailed booklet, they were encouraged to contact the genetic counselor to address any further questions or concerns but no participants initiated a telephone call to the genetic counselor during the study's duration.
Three-Month Follow-up Results
Participant Satisfaction with Mode of Results Delivery
Three months after receiving their genomic risk information, 103 of 117 (85%) participants completed a follow-up questionnaire. Overall, participants were highly satisfied with their delivery of results, reporting an average score of 3.4 on a 1 to 4 scale (SD 0.5) using the Baumanis genetic counseling satisfaction scale (Table 3) . Satisfaction was similar for participants who received their results by telephone (mean 3.4, SD 0.5) or mailed booklet (3.4, SD 0.5). Risk category, age or sex were not significantly associated with participant satisfaction.
Participant Satisfaction with Information Received
When participants were asked how satisfied they were with the information they received during the telephone call, participants reported high satisfaction (mean 8.4, SD 1.8) on a 0-10 scale. There was no significant difference in satisfaction between participants who received their results over the telephone (mean 8.5, SD 1.8) and those who received their results via mailed booklet (mean 8.2, SD 2.0).
Participants also reported high satisfaction with the information they received from their mailed personalized booklet (mean 8.7, SD 1.5). There was no significant difference in satisfaction between participants who received their risk result over the telephone (mean 8.8, SD 1.2) and those who received their result via mailed booklet only (mean 8.1, SD 2.4, p-value 0.08). Risk category, age, and sex were not significantly associated with participant satisfaction of delivery mode.
Participant Recall of Results
Participants were asked to recall the risk category they received (low, average or high), with 77 out of 103 (75%) correctly recalling their specific risk category (Table 4 ). The accuracy of recalling risk category was not significantly related to delivery mode, risk category, age or sex.
Participant Acceptability with Mode of Result Delivery
Of the participants who received their result via telephone, 5 (6%) reported that they would have preferred to receive their result a different way. Four of these participants stated they would have preferred to receive their result electronically (via email or online) and one participant stated in-person due to their hearing difficulties.
Of the participants who received their result via mailed booklet, 3 (18%) reported that they would have preferred to receive their result a different way: one participant stated via General Practitioner (GP), one participant stated via email and one participant stated via either GP or email. Preference for receiving a result in a different way was not significantly related to mode of delivery or risk category.
Modifications to the Communication Protocol
Several participants commented to the genetic counselor that they thought their genomic risk result would be higher given their previous sun exposure. To ensure that participants understood that their genomic risk result did not incorporate traditional (non-genetic) melanoma risk factors, the additional statement of BHowever, this does not take into account nongenetic risk factors, such as past sunburns^was given verbally by the genetic counselor after informing participants of their risk result and was also written in the mailed booklet.
Discussion
Most participants in this research setting opted to receive genomic risk results via telephone accompanied by written materials, rather than by written materials only. All participants reported high satisfaction with the delivery of their risk results via telephone genetic counseling. A small number of participants indicated a preference for receiving their risk result via a different mode of delivery, either in an electronic format or 
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(4%)
BSo the idea of this study was to prove if it [melanoma] was genetic, so have you proved anything in that? (male, 69, average) face-to-face with their GP. We have previously reported that the majority of participants indicated they read either all or most of the mailed booklet (Smit et al. 2017) , and they reported high satisfaction with the information it contained. Satisfaction with services and information received as part of genetic counseling is a measure of the quality of genetic counseling (Kasparian et al. 2007 ) and high satisfaction with telephone genetic counseling has been observed in clinical and research settings (Baumanis et al. 2009; Buchanan et al. 2016; Christensen et al. 2011; Jenkins et al. 2007 ). Baumanis et al. (2009) evaluated patient satisfaction with BRCA1/2 genetic test results disclosed over the telephone and reported a mean satisfaction score of 3.6 out of 4. We implemented the same survey (omitting one question) and found a similar mean satisfaction score of 3.4. Baumanis et al. (2009) reported two factors in the result disclosure process that were significantly related to greater patient satisfaction: 1) giving a choice of how they received their result and 2) receiving their result within one week of knowing it was available. In our study, all participants were given a choice of how to receive their results. Additionally, once the genetic counselor made contact with the participants to inform them their results were available, each participant either elected to receive it immediately during that same telephone call or to receive it via mailed booklet that was posted within three days of the telephone call. Therefore, all participants in our study received their result within one week of knowing it was available. These factors in our study may have contributed to the similar satisfaction scores between the two different delivery modes in our study. The longer waiting period between giving the saliva sample and receiving results for the waitlist control group (7 months versus 3.5 months for the intervention group) also did not impact participants' satisfaction with genetic counseling.
Several studies support providing individuals with a choice of how genetic counseling is delivered, including the mode of result delivery, indicating that this client-led approach leads to improved satisfaction (Baumanis et al. 2009; Sie et al. 2014; Smit et al. 2016) . Sie et al. (2014) have shown a preference by breast cancer patients for replacing a face-to-face genetic counseling session prior to genetic testing with telephone, written and digital information. High satisfaction with telephone genetic counseling prior to genetic testing was reported (Sie et al. 2014) and no increase in psychological distress at either short or long term follow up was observed (Sie et al. 2016) . In our study, we did not find evidence of increased skin-cancer related worry or general psychological distress at 3-months follow up for any of the risk groups (Smit et al. 2017) . Our findings suggest that disclosing genomic risk information in a format that is not face-to-face is acceptable by the general population and does not result in negative health outcomes.
Despite the majority of participants accurately recalling their risk result category at 3-months follow up, a quarter of Table 3 Genetic counseling satisfaction survey scores Low (n = 23) Average (n = 48) High (n = 29) Overall (n = 100*)
An adequate / clear explanation was given with my risk information 3.6 (0.5) 3.6 (0.5) 3.4 (0.6) 3.5 (0.5)
My risk information was conveyed in a sensitive manner 3.6 (0.5) 3.6 (0.5) 3.5 (0.5) 3.6 (0.5)
All of my concerns were addressed 3.6 (0.5) 3.5 (0.5) 3.2 (0.6) 3.4 (0.6) I was encouraged to call the genetic counselor if I had questions 3.6 (0.5) 3.5 (0.5) 3.4 (0.5) 3.5 (0.5) I felt I could talk about my reaction to my risk information 3.6 (0.5) 3.5 (0.5) 3.2 (0.6) 3.4 (0.6) Getting my risk information was convenient 3.6 (0.5) 3.5 (0.5) 3.4 (0.5) 3.5 (0.5)
I was satisfied overall with the way my risk information was delivered 3.6 (0.5) 3.6 (0.5) 3.5 (0.5) 3.6 (0.5)
I felt a connection with the genetic counselor 3.1 (0.6) 3 (0.6) 2.9 (0.5) 3 (0.5) The length of the phone call was appropriate 3.7 ( (Gurmankin et al. 2005; Hallowell et al. 1997; Smerecnik et al. 2009; Vos et al. 2012b ). Vos et al. (2012a) found around 75% of patients who had undergone BRCA1/2 testing could accurately recall their result category at 3-months post result disclosure, yet recall of numerical risk estimates was much lower. Inaccurate result recall has been attributed to a wide range of factors including a misunderstanding of the information, especially ambiguous or complex results; an inability to commit the information to memory; and resistance to the communicated risk information as it may refute preconceived risk perceptions (Gurmankin et al. 2005; Hallowell et al. 1997; Lloyd et al. 1996; Vos et al. 2012a, b) . In our study, one possibility for some participants recalling a lower risk category is that in the mailed booklet we presented a relative risk estimate (relative to the mean genetic risk score) alongside the risk category. Because the genetic risk score had a right skew distribution (mean score was 1 but median was 0.8) this meant that about three quarters of participants in the 'average-risk' category had a relative risk lower than 1 despite being in the middle 50% of the risk distribution. This may have led to participants misinterpreting their average-risk category as low-risk. Based on our findings, we recommend that future presentations of genomic risk do not include a relative risk estimate alongside the absolute risk and risk category, as has been advised by others (Edwards et al. 2008) . We have previously shown that participants had a high risk perception of developing melanoma during their lifetime (recorded as a percentage, mean 42%, SD 25) and this risk perception was non-significantly reduced following the delivery of their risk results (Smit et al. 2017) . Our study shows that the most prevalent discussion topics for asymptomatic individuals in the general population undergoing genomic testing for melanoma were: options for prevention and detection of melanoma; the familial impact of the risk result; and information regarding how their risk was determined. These results are partly in line with findings from other research. Salemink et al. (2013) found that patients undergoing genetic counseling for hereditary colorectal cancer were most interested in information on familial colorectal risk and surveillance options, whereas general information on genetics was deemed less important. In our study, participants need for information around their risk result, particularly how the genes related to melanoma and how their risk was calculated, may reflect the novelty and low level of awareness of genomic testing in the general population (Cherkas et al. 2010; Schmidlen et al. 2014) .
Almost half of the participants did not raise any discussion topics with the genetic counselor and there was an overall lack of uptake of additional (unscheduled) genetic counseling access throughout the study. A recent longitudinal study investigating the informational needs of individuals receiving personalized genomic results has shown limited utilization of genetic counseling services among consumers of personal genome testing (Schmidlen et al. 2014 ). Schmidlen et al.'s (2014) study found that the majority of these individuals will not need or perceive a need for genetic counseling or additional explanation of results. This was thought to be because individuals who seek personalized genomic testing often have either a personal or familial experience of the condition that contributes to a background level of understanding, and they were likely to be already familiar with, or engaging in, recommended risk reduction behaviors. Our sample was from the general population but had a relatively high proportion of participants with a family history of melanoma or a personal and/or family history of other cancers; they also had higher-thanaverage education levels and a strong interest in cancer research. These characteristics may have reduced the need to gain further information from the genetic counselor. It will be important to assess the generalizability of our findings to the wider population. Foulkes et al. (2016) proposed that population-based genetic testing for cancer susceptibility as well as wholegenome/exome sequencing is likely to become integrated into public health programs in the future, and as a consequence developing new competencies in communication and counseling in this setting is urgently required. In line with these anticipations for the future use of genomics-based disease risk information, our study contributes insights into how genomic risk results could be delivered to the general population and its potential impact. In addition, the findings from the pilot study suggest potential beneficial impacts of genomic testing for melanoma with respect to skin cancer prevention behaviors (Smit et al. 2017) , and a larger study recruiting directly from the Australian general population is underway to investigate these behavioral and psychological outcomes further.
In conclusion, participants reported high satisfaction and acceptability of receiving their personalized genomic risk of melanoma over the telephone with accompanying written material, or via written material only with a follow-up telephone call for those at high risk. The majority of participants chose to receive their results over the telephone with accompanying written material. This process would be a feasible mode of result delivery in the general population, particularly for common polygenic diseases, in the context of increasing demands for genomic testing.
